ESC 365 - Welcome and opening remarks: confronting the burden of LDL-C in Asia

ESC Premium Access

Welcome and opening remarks: confronting the burden of LDL-C in Asia

Session: Understanding PCSK9 Inhibitors: what, when and why?

Topic: PCSK9-Antagonists

Speaker: Associate Professor J. Tan (Singapore, SG)

Sponsored by Amgen

Event: ESC Asia with APSC & AFC

Congress Presentation

About the speaker

Associate Professor Jack Wei Chieh Tan

National Heart Centre Singapore, Singapore (Singapore)

13 presentations

2 followers

3 more presentations in this session

PCSK9 Inhibitors: deep dive into guidelines and clinical data

Speaker: Associate Professor K. Kostner (Brisbane, AU)

Treating patients in the real world

Speaker: Professor S. Uemura (Kurashiki, JP)

Questions and answers and closing remarks

Speaker: Associate Professor J. Tan (Singapore, SG)

Access the full session

Understanding PCSK9 Inhibitors: what, when and why?

Speakers: Associate Professor J. Tan, Associate Professor K. Kostner, Professor S. Uemura, Associate Professor J. Tan

About the event

ESC Asia with APSC & AFC

8 November - 10 November 2019

Sessions Presentations

Congress

ESC 365 is supported by